G6PD Cancer Research Results
G6PD, Glucose-6-phosphate dehydrogenase: Click to Expand ⟱
| Source: |
| Type: |
Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme that plays a crucial role in the pentose phosphate pathway (PPP), a metabolic pathway that generates NADPH and pentoses from glucose-6-phosphate. G6PD is the first enzyme in the PPP and is responsible for catalyzing the conversion of glucose-6-phosphate to 6-phosphogluconate, producing NADPH in the process.
**** patients who receive intravenous ascorbate must be prescreened for glucose 6 phosphate dehydrogenase deficiency.
G6PD expression is often elevated in various cancers and is generally linked to poorer prognosis.
|
Scientific Papers found: Click to Expand⟱
*neuroP↑, *BioAv↓, *Half-Life↓, *BioAv↑, *BBB↑, *NRF2↑, *BioAv↓, *BioAv↑, *SIRT1↑, *cognitive↑, *lipid-P↓, *HO-1↑, *SOD↑, *GSH↑, *GPx↑, *G6PD↑, *PPARγ↑, *AMPK↑, *Aβ↓,
*GlucoseCon↓, *ROS↓, *Trx↓, *HK2↓, *NRF2↑, *Catalase↑, *TXNIP↑, *PFKFB2↓, *G6PD↑,
*neuroP↑, *Inflam↓, *ATP↑, *G6PD↑, *NADPH↑, *IL1β↓, *other↝,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Total Targets: 0
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
Catalase↑, 1, GPx↑, 1, GSH↑, 1, HO-1↑, 1, lipid-P↓, 1, NRF2↑, 2, ROS↓, 1, SOD↑, 1, Trx↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, G6PD↑, 3, GlucoseCon↓, 1, HK2↓, 1, NADPH↑, 1, PFKFB2↓, 1, PPARγ↑, 1, SIRT1↑, 1,
Transcription & Epigenetics ⓘ
other↝, 1,
Migration ⓘ
TXNIP↑, 1,
Barriers & Transport ⓘ
BBB↑, 1,
Immune & Inflammatory Signaling ⓘ
IL1β↓, 1, Inflam↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, BioAv↑, 2, Half-Life↓, 1,
Functional Outcomes ⓘ
cognitive↑, 1, neuroP↑, 2,
Total Targets: 29
Scientific Paper Hit Count for: G6PD, Glucose-6-phosphate dehydrogenase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:808 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page